Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-STOXX 50 ready to break out its range after ZEW?

Wed, 16th Sep 2020 12:41

* European shares higher

* Eyes on Fed policy meeting

* Retailers lead gainers after Inditex results

* The Hut Group soars in London IPO debut
Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters. You can share your thoughts with Joice Alves (joice.alves@thomsonreuters.com)
and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Danilo Masoni
(danilo.masoni@thomsonreuters.com) and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in
Milan.

STOXX 50 READY TO BREAK OUT ITS RANGE AFTER ZEW? (1140 GMT)

Yesterday's ZEW data showed that investor sentiment in Germany rose to 77.4 in September
signaling confidence in a recovery from a virus-induced recession.

This is a fact, but there could be more.

Saxo Bank, which looked at all samples since December 1991 where the ZEW was above 60 and
had a positive month-to-month reading, says this is "skewing the probability in favour of an
upside breakout for the STOXX 50 index" which has been trading in a tight range for six weeks.

A strong momentum in equity market "continues in the subsequent two months,” of the releases
of ZEW data, a Saxo Bank research note says.

"The median path ends up 3.3% after two months and the win ratio is 66%," it adds.

But more importantly "the interquartile range goes from -2.6% (25% percentile) to +7.2% (75%
percentile) indicating a distribution that is heavily skewed towards positive numbers,
increasing our conviction that the ZEW number yesterday will lead to positive European equities
over the coming months," it adds.

(Stefano Rebaudo)

*****

ITALIAN VOTE: LITTLE TO WORRY ABOUT (1034 GMT)

This time we shouldn't be worried too much about political uncertainty in Italy ahead of
next weekend's vote since, if everything goes as expected, a "yes" victory in a constitutional
referendum should support the current government.

Usually political instability in Italy triggers a rise in risk premia for Italian assets
with the closely watched yield spread between Italian and German government bonds widening.

Citi analysts do not expect this to happen in the near-term but they see instead a declining
trend for Italian rates as more likely.

Recent polls indicate a centre-right victory in regional elections that will be held along
with the referendum. That would not help the government of the prime minister Giuseppe Conte.

But they also forecast a "yes" result for the referendum aimed at reducing the number of
Parliament members, which will be major win for the 5-Star Movement (M5S) and reduce risks of a
near-term snap election, a Citi research note says.

If we are interested in rates we should turn our attention to next week's TLTRO and a
declining supply pressure in Q4, which will be supportive for Italian Btp.

(Stefano Rebaudo)

*****

CHALLENGING THE CONVENTIONAL WISDOM OF INVESTING IN EUROPE (0904 GMT)

The conventional wisdom is that Europe is primarily a value play but the composition of its
equity market is progressively changing, meaning that sooner or later investors may have to
rethink their views (and perhaps allocations) on the region.

Morgan Stanley is looking into this evolution and a while back it argued that the changing
sector mix of the European market with more tech and less banks will lead to higher profit
growth and less volatility.

After feedback from investors, strategists at the U.S. bank have returned to the issue,
pointing out a few facts about that may surprise you:

* At 14% Technology is the largest sector in the EuroSTOXX50 and likely to get even larger
at the
September rebalance

* After the rebalance, the index's Value exposure will be the lowest in a decade, Growth
exposure
is at a decade high

* The weighting in Value stocks in the UK is now close to a record high

* Healthcare and Consumer Staples are now the largest components of MSCI Europe, accounting
for
31% of the index together

* Semis has a larger market cap than Autos

* Europe is not overweight Banks (relative to MSCI ACWI)

* The largest stock in the European Retailing sector is Prosus

* Netherlands has a higher correlation to Nasdaq than any European sector (including Tech!)

* The Danish stock market is bigger than either Italy or Spain
(Danilo Masoni)
*****

OPENING SNAPSHOT: BUYING RETAILERS, EYES ON THE FED (0743 GMT)

European stocks are slightly higher, supported by the retail sector after stronger than
expected results from Zara owner Inditex.

Investors are reluctant to take big positions ahead of today's Federal Reserve policy
meeting. Their focus is on the central bank's economic view with some expectations it might take
further steps on the accommodative side.

Travel and leisure stocks are still under pressure after Lufthansa said it could
cut its fleet by 130 planes, 30 planes more than recently panned.

Europe's STOXX 600 index is up 0.2% led by Retailers, up 1.4%, while Travel and
Leisure stocks are the worst performers, down 0.4%

Inditex is up 5.5% after the company returned to quarterly profit though reported
sales down 31% on the year-ago period. Sweden’s Handelsbanken is up 3.3% as the
company will reduce its workforce and number of branches.

A whooping 30% rise for The Hut Group in its first day of trading on the London
Stock Exchange to seal the first major British initial public offering since the start of the
COVID-19 crisis.

(Stefano Rebaudo)

*****

ON THE RADAR: ASTRAZENECA, THE HUT GROUP, HANDELSBANKEN (0644 GMT)

European stocks are set to open slightly lower as investors wait for Federal Reserve policy
statement and economic view later today.

Vaccine developments are still on the frontline after the U.S. Food and Drug Administration
confirmed AstraZeneca's U.S. COVID-19 vaccine trial is on hold, as it conducts its
investigation after an illness in a participant in Britain.

Meanwhile in India, the local drugs regulator has given approval to Serum Institute of India
to resume clinical trials of the potential vaccine developed by AstraZeneca and Oxford
University, according to a Times of India report.

In London, e-commerce firm The Hut Group is preparing for its first day of trading
after batting away corporate governance concerns to seal the first major British initial public
offering since the start of the COVID-19 crisis.

Elsewhere, Handelsbanken will reduce its number of branches to around 200 from 380
by the end of 2021 and reduce its workforce, affecting around 1,000 employees in Sweden over the
next two years, as part of a review of the group's business operations.

Eyes also on Lufthansa which could cut its fleet by 130 planes in response to the
coronavirus crisis, 30 planes more than recently panned.

In results, fashion retailer Inditex, owner of Zara, returned to quarterly profit
in the three months from May to July but reported sales down 31% on the year-ago period.

There could be a positive readacross for Deutsche Post and Royal Mail
from stronger than expected results at U.S. delivery firm FedEx.

Finally Atlantia is ready to approve the listing of its motorway assets as early as
next week, challenging the solution favoured by the Rome government to solve a long-running
dispute with the infrastructure group.

(Stefano Rebaudo)

*****

MORNING CALL: WAITING FOR THE FED (0528 GMT)

European stock futures are hovering around yesterday levels with no clear direction as
investors await a Federal Reserve policy statement later today.

Yesterday’s upbeat U.S. and China macro data increased risk sentiment, but concerns about
the economy remain on fears of a second wave of virus-induced restrictions as well as a
political impasse over a new relief package in the U.S.

The Fed policy meeting which ends today is the first one since chairman Jerome Powell
announced a new stance on inflation and some analysts hope the U.S. central bank might take a
step forward on the accommodative side.

(Stefano Rebaudo)

*****

More News
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.